Drug Profile
Epoetin alfa biosimilar - Sandoz
Alternative Names: Abseamed; Aczicrit; Binocrit; Epoetin alfa Hexal; Epoetin lambda - Sandoz; Grandicrit; HX 575; HX 575 epoetin alfa; HX 575, recombinant epoetin alfa; NovicritLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Sandoz
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 05 Apr 2021 Launched for Anaemia in Ukraine (SC) prior to April 2021
- 05 Apr 2021 Registered for Anaemia in Ukraine (SC) prior to April 2021
- 31 Oct 2018 No development reported - Phase-III for Anaemia in USA (SC)